The Diabetes Risk Score
Tóm tắt
OBJECTIVE—Interventions to prevent type 2 diabetes should be directed toward individuals at increased risk for the disease. To identify such individuals without laboratory tests, we developed the Diabetes Risk Score.
RESEARCH DESIGN AND METHODS—A random population sample of 35- to 64-year-old men and women with no antidiabetic drug treatment at baseline were followed for 10 years. New cases of drug-treated type 2 diabetes were ascertained from the National Drug Registry. Multivariate logistic regression model coefficients were used to assign each variable category a score. The Diabetes Risk Score was composed as the sum of these individual scores. The validity of the score was tested in an independent population survey performed in 1992 with prospective follow-up for 5 years.
RESULTS—Age, BMI, waist circumference, history of antihypertensive drug treatment and high blood glucose, physical activity, and daily consumption of fruits, berries, or vegetables were selected as categorical variables. Complete baseline risk data were found in 4,435 subjects with 182 incident cases of diabetes. The Diabetes Risk Score value varied from 0 to 20. To predict drug-treated diabetes, the score value ≥9 had sensitivity of 0.78 and 0.81, specificity of 0.77 and 0.76, and positive predictive value of 0.13 and 0.05 in the 1987 and 1992 cohorts, respectively.
CONCLUSIONS—The Diabetes Risk Score is a simple, fast, inexpensive, noninvasive, and reliable tool to identify individuals at high risk for type 2 diabetes.
Từ khóa
Tài liệu tham khảo
Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 20: 537–544, 1997
Tuomilehto J, Lindström J, Eriksson J, Valle T, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Aunola S, Cepaitis Z, Moltchanov V, Hakumäki M, Mannelin M, Martikkala V: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350, 2001
Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403, 2002
DECODE Study Group: Will new diagnostic criteria for diabetes mellitus change the phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 317:371–375, 1998
Salomaa V, Korhonen HJ, Tuomilehto J, Vartiainen E, Pietinen P, Kartovaara L, Gref CG, Nissinen A, Puska P: Serum cholesterol distribution, measurement frequency and cholesterol awareness in three geographical areas of Finland. Eur Heart J 11:294–301, 1990
Tuomilehto J, Korhonen HJ, Kartovaara L, Salomaa V, Stengård JH, Pitkänen M, Aro A, Javela K, Uusitupa M, Pitkäniemi J: Prevalence of diabetes mellitus and impaired glucose tolerance in the middle-aged population of three areas in Finland. Int J Epidemiol 20:1010–1017, 1991
Vartiainen E, Korhonen HJ, Pietinen P, Tuomilehto J, Kartovaara L, Nissinen A, Puska P: Fifteen-year trends in coronary risk factors in Finland, with special reference to North Karelia. Int J Epidemiol 20:651–662, 1991
Tuomilehto J, Arstila M, Kaarsalo E, Kankaanpää J, Ketonen M, Kuulasmaa K, Lehto S, Miettinen H, Mustaniemi H, Palomäki P, Puska P, Pyörälä K, Salomaa V, Torppa J, Vuorenmaa T: Acute myocardial infarction (AMI) in Finland: baseline data from the FINMONICA AMI register in 1983–1985. Eur Heart J 13:577–587, 1992
Vartiainen E, Puska P, Pekkanen J, Tuomilehto J, Jousilahti P: Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ 309:23–27, 1994
Lowry R: Clinical Calculator 1 from an observed sample: estimates of population prevalence, sensitivity, specificity, predictive values, and likelihood ratios, 2001. Available from http://faculty.vassar.edu/lowry/clin1.html. Accessed 20 December 2001
Silman AJ: Epidemiological Studies: A Practical Guide. Cambridge, UK, Cambridge University Press, 1995
Alberti K, Zimmet P, for a WHO Consultation: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Organization, 1999
Lean M, Han T, Morrison C: Waist circumference as a measure for indicating need for weight management. BMJ 311:158–161, 1995
Herman WH, Smith PJ, Thompson TJ, Engelgau MM, Aubert R: A new and simple questionnaire to identify persons at increased risk for undiagnosed diabetes mellitus. Diabetes Care 18:382–387, 1995
Ruige JB, de Neeling JN, Kostense PJ, Bouter LM, Heine RJ: Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabetes Care 20:491–496, 1997
Baan CA, Ruige JB, Stolk RP, Witteman JC, Dekker JM, Heine RJ, Feskens EJ: Performance of a predictive model to identify undiagnosed diabetes in a health care setting. Diabetes Care 22:213–219, 1999
Griffin S, Little P, Hales C, Kinmonth A, Wareham N: Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 16:164–171, 2000
Lawrence J, Bennett P, Young A, Robinson A: Screening for diabetes in general practice: cross sectional population study. BMJ 323:548–551, 2001
Park PJ, Griffin SJ, Sargeant L, Wareham NJ: The performance of a risk score in predicting undiagnosed hyperglycemia. Diabetes Care 25:984–988, 2002
Rolandsson O, Hägg E, Nilson M, Hallmans G, Mincheva-Nilsson L, Lernmark Å: Prediction of diabetes with body mass index, oral glucose tolerance test and islet cell autoantibodies in a regional population. J Intern Med 249:279–288, 2001
Stern MP, Williams K, Haffner SM: Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 136:575–581, 2002
Kekäläinen P, Pyörälä K, Sarlund H, Laakso M: Hyperinsulinemia cluster predicts the development of type 2 diabetes independently of family history of diabetes. Diabetes Care 22:86–92, 1999
Jacob Reichelt AA, Ferraz TM, Rocha Oppermann ML, Costa e Forti A, Duncan BB, Fleck Pessoa E, Schmidt MI: Detecting glucose intolerance after gestational diabetes: inadequacy of fasting glucose alone and risk associated with gestational diabetes and second trimester waist-hip-ratio. Diabetologia 45:455–457, 2002
Kim C, Newton KM, Knopp RH: Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25:1862–1868, 2002
Lynch J, Helmrich S, Lakka TA, Kaplan GA, Cohen RD, Salonen R, Salonen JT: Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men. Arch Intern Med 156:1307–1314, 1996
Hu FB, Sigal RJ, Rich-Edwards J, Colditz GA, Solomon CG, Willett W, Speizer FE, Manson JE: Walking compared with vigorous physical activity and risk of type 2 diabetes in women. JAMA 282:1433–1439, 1999
Feskens EJ, Virtanen SM, Räsänen L, Tuomilehto J, Stengård J, Pekkanen J, Nissinen A, Kromhout D: Dietary factors determining diabetes and impaired glucose tolerance: a 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetes Care 18:1104–1112, 1995
Feskens E, van Dam R: Dietary fat and the etiology of type 2 diabetes: an epidemiological perspective. Nutr Metab Cardiovasc Dis 9:87–95, 1999
Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willet WC: Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345:790–797, 2001
Valle T, Tuomilehto J, Eriksson J: Epidemiology of type 2 diabetes in Europids. In International Textbook of Diabetes Mellitus. 2nd ed. Alberti K, Zimmet P, DeFronzo R, Keen H, Eds. New York, John Wiley and Sons, 1997, p. 125–142
Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer H-M, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey 1988–1994. Diabetes Care 21:518–524, 1998
DECODE Study Group: Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354:617–621, 1999
DECODE Study Group: Glucose tolerance and cardiovascular mortality comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397–404, 2001
Finnish Diabetes Association: Development programme for the prevention and care of diabetes in Finland 2000–2010, 2001. Available fromhttp://www.diabetes.fi/english/programme/. Accessed 30 October 2002